SIRIO(SZ:300791) Xin Lang Cai Jing·2025-11-14 12:10Core Insights - The article highlights the innovative advancements of Xianle Health at the recent China International Import Expo (CIIE), showcasing their WELMAX evidence-based nutrition technology platform and a focus on six high-potential sectors [1][2] - Xianle Health emphasizes the integration of artificial intelligence in their product development, enabling personalized nutrition solutions through AI nutritionists [1] - The company has initiated strategic collaborations, including a partnership with doTERRA to co-develop essential oil-infused nutritional health products [1][2] Group 1 - Xianle Health launched multiple new products at the CIIE, leveraging the WELMAX platform to create a comprehensive evidence-based approach from raw material selection to product launch [2] - The company is collaborating with the China National Institute of Standardization and the China Nutrition and Health Food Association to establish a group standard for DHA algal oil nutritional product formulation and production technology [2] - Clinical evidence is a cornerstone of the WELMAX platform, with partnerships established with top-tier hospitals to conduct high-quality clinical research, ensuring authoritative validation of product value [2] Group 2 - The CIIE serves as a platform for Xianle Health to introduce diverse cross-border solutions, enhancing the accessibility of global nutritional resources [1] - The health and wellness sector is being redefined through innovative technologies, with a focus on creating new experiences in nutritional supplementation [1] - Xianle Health aims to continue fostering a new ecosystem of nutrition, contributing to high-quality industry development [2]